<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>HYDROCODONE BITARTRATE AND ACETAMINOPHEN- hydrocodone bitartrate and acetaminophen solution </strong><br>VistaPharm Inc.<br></p></div>
<h1>Hydrocodone Bitartrate and Acetaminophen Oral Solution<br> 7.5 mg/325 mg per 15 mL (Cherry Flavored)<br> CII</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="DLDE"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<p class="First">Rx Only</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-2"></a><p></p>
<h1>WARNING</h1>
<div class="Warning">
<a name="BOX"></a><a name="section-2.1"></a><p></p>
<h2><span class="Emphasis">HEPATOTOXICITY</span></h2>
<p class="First"><span class="Bold">ACETAMINOPHEN HAS BEEN ASSOCIATED WITH CASES OF <span class="product-label-link" type="condition" conceptid="4026032" conceptname="Acute hepatic failure">ACUTE LIVER FAILURE</span>, AT TIMES RESULTING IN LIVER TRANSPLANT AND <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">DEATH</span>. MOST OF THE CASES OF <span class="product-label-link" type="condition" conceptid="4352876" conceptname="Liver damage">LIVER INJURY</span> ARE ASSOCIATED WITH THE USE OF ACETAMINOPHEN AT DOSES THAT EXCEED 4000 MILLIGRAMS PER DAY, OFTEN IN COMBINATION WITH OTHER ACETAMINOPHEN-CONTAINING PRODUCTS.</span></p>
</div>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-3"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Hydrocodone bitartrate and acetaminophen is supplied in liquid form for oral administration.</p>
<p><span class="Bold">WARNING: May be habit-forming </span>(see<a href="#info"> PRECAUTIONS, Information for Patients/Caregivers</a>, and<a href="#DAD"> DRUG ABUSE AND <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">DEPENDENCE</span></a>).</p>
<p>Hydrocodone bitartrate is an opioid analgesic and antitussive and occurs as fine, white crystals or as a crystalline powder. It is affected by light. The chemical name is 4,5α-epoxy-3-methoxy-17-methylmorphinan-6-one tartrate (1:1) hydrate (2:5). It has the following structural formula:</p>
<div class="Figure">
<img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=41ebe34d-567d-4fea-9fcb-c93e990a7861&amp;name=hydrocodone-01.jpg"><p class="MultiMediaCaption">C<span class="Sub">18</span>H<span class="Sub">21</span>NO<span class="Sub">3</span>• C<span class="Sub">4</span>H<span class="Sub">6</span>O<span class="Sub">6</span>• 2½ H<span class="Sub">2</span>O         M.W. 494.49</p>
</div>
<p>Acetaminophen, 4'-hydroxyacetanilide, a slightly bitter, white, odorless, crystalline powder, is a non-opiate, non-salicylate analgesic and antipyretic. It has the following structural formula:</p>
<div class="Figure">
<img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=41ebe34d-567d-4fea-9fcb-c93e990a7861&amp;name=hydrocodone-02.jpg"><p class="MultiMediaCaption">C<span class="Sub">8</span>H<span class="Sub">9</span>NO<span class="Sub">2</span>         MW = 151.16</p>
</div>
<table width="75%">
<col align="left" valign="top" width="60%">
<col align="center" valign="top" width="20%">
<col align="center" valign="top" width="20%">
<thead><tr class="First Last">
<th class="Lrule Rrule" align="left">Hydrocodone bitartrate and acetaminophen oral solution contains:</th>
<th class="Rrule" align="center">Per 5 mL</th>
<th class="Rrule" align="center">Per 15 mL</th>
</tr></thead>
<tbody>
<tr class="Botrule First">
<td class="Lrule Rrule" align="left">Hydrocodone Bitartrate</td>
<td class="Rrule" align="center">2.5 mg</td>
<td class="Rrule" align="center">7.5 mg</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">Acetaminophen</td>
<td class="Rrule" align="center">108 mg</td>
<td class="Rrule" align="center">325 mg</td>
</tr>
<tr class="Last">
<td class="Lrule Rrule" align="left">Alcohol</td>
<td class="Rrule" align="center">8.6% v/v</td>
<td class="Rrule" align="center">8.6% v/v</td>
</tr>
</tbody>
</table>
<p>In addition, the liquid contains the following inactive ingredients: citric acid anhydrous, ethyl maltol, glycerin, methylparaben (preservative), propylene glycol, propylparaben (preservative), purified water, saccharin sodium, sodium citrate dihydrate, sorbitol solution, sucrose, FD&amp;C Red #40 as coloring and artificial wild cherry as flavoring.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-4"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Hydrocodone is a semisynthetic narcotic analgesic and antitussive with multiple actions qualitatively similar to those of codeine. Most of these involve the central nervous system and smooth muscle. The precise mechanism of action of hydrocodone and other opiates is not known, although it is believed to relate to the existence of opiate receptors in the central nervous system. In addition to <span class="product-label-link" type="condition" conceptid="4242687" conceptname="No sensitivity to pain">analgesia</span>, narcotics may produce <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, changes in mood and mental clouding.</p>
<p>The analgesic action of acetaminophen involves peripheral influences, but the specific mechanism is yet undetermined. Antipyretic activity is mediated through hypothalamic heat regulating centers.</p>
<p>Acetaminophen inhibits prostaglandin synthetase. Therapeutic doses of acetaminophen have negligible effects on the cardiovascular or respiratory systems; however, toxic doses may cause <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">circulatory failure</span> and rapid, <span class="product-label-link" type="condition" conceptid="4302536" conceptname="Shallow breathing">shallow breathing</span>.</p>
<div class="Section" data-sectionCode="43682-4">
<a name="section-4.1"></a><p></p>
<h2>Pharmacokinetics</h2>
<p class="First">The behavior of the individual components is described below.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="section-4.1.1"></a><p></p>
<h3>Hydrocodone</h3>
<p class="First">Following a 10 mg oral dose of hydrocodone administered to five adult male subjects, the mean peak concentration was 23.6 ± 5.2 ng/mL. Maximum serum levels were achieved at 1.3 ± 0.3 hours and the half-life was determined to be 3.8 ± 0.3 hours. Hydrocodone exhibits a complex pattern of metabolism including O-demethylation, N-demethylation and 6-keto reduction to the corresponding 6-α-and 6-β-hydroxymetabolites. See<a href="#OVERDOSAGE"> OVERDOSAGE </a>for toxicity information.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-4.1.2"></a><p></p>
<h3>Acetaminophen</h3>
<p class="First">Acetaminophen is rapidly absorbed from the gastrointestinal tract and is distributed throughout most body tissues. The plasma half-life is 1.25 to 3 hours, but may be increased by <span class="product-label-link" type="condition" conceptid="4352876" conceptname="Liver damage">liver damage</span> and following overdosage. Elimination of acetaminophen is principally by liver metabolism (conjugation) and subsequent renal excretion of metabolites. Approximately 85% of an oral dose appears in the urine within 24 hours of administration, most as the glucuronide conjugate, with small amounts of other conjugates and unchanged drug. See<a href="#OVERDOSAGE"> OVERDOSAGE </a>for toxicity information.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-5"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Hydrocodone bitartrate and acetaminophen oral solution is indicated for the relief of moderate to moderately severe <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-6"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">This product should not be administered to patients who have previously exhibited <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to hydrocodone, acetaminophen, or any other component of this product. Patients known to be hypersensitive to other opioids may exhibit cross-sensitivity to hydrocodone.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-7"></a><p></p>
<h1>WARNINGS</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="section-7.1"></a><p></p>
<h2>Hepatotoxicity</h2>
<p class="First">Acetaminophen has been associated with cases of <span class="product-label-link" type="condition" conceptid="4026032" conceptname="Acute hepatic failure">acute liver failure</span>, at times resulting in liver transplant and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>. Most cases of <span class="product-label-link" type="condition" conceptid="4352876" conceptname="Liver damage">liver injury</span> are associated with the use of acetaminophen at doses that exceed 4000 milligrams per day, and often involve more than one acetaminophen-containing product. The excessive intake of acetaminophen may be intentional to cause self-harm or unintentional as patients attempt to obtain more <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> relief or unknowingly take other acetaminophen-containing products.</p>
<p>The risk of <span class="product-label-link" type="condition" conceptid="4026032" conceptname="Acute hepatic failure">acute liver failure</span> is higher in individuals with underlying liver disease and in individuals who ingest alcohol while taking acetaminophen.</p>
<p>Instruct patients to look for acetaminophen or APAP on package labels and not to use more than one product that contains acetaminophen. Instruct patients to seek medical attention immediately upon ingestion of more than 4000 milligrams of acetaminophen per day, even if they feel well.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="section-7.1.1"></a><p></p>
<h3>Serious <span class="product-label-link" type="condition" conceptid="4089139" conceptname="Skin reaction">skin reactions</span></h3>
<p class="First">Rarely, acetaminophen may cause serious <span class="product-label-link" type="condition" conceptid="4089139" conceptname="Skin reaction">skin reactions</span> such as <span class="product-label-link" type="condition" conceptid="45773387" conceptname="Acute generalized exanthematous pustulosis">acute generalized exanthematous pustulosis</span> (<span class="product-label-link" type="condition" conceptid="45773387" conceptname="Acute generalized exanthematous pustulosis">AGEP</span>), <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">Stevens-Johnson Syndrome</span> (SJS), and <span class="product-label-link" type="condition" conceptid="443754" conceptname="Lyell's toxic epidermal necrolysis, subepidermal type">toxic epidermal necrolysis</span> (TEN), which can be fatal. Patients should be informed about the signs of serious <span class="product-label-link" type="condition" conceptid="4089139" conceptname="Skin reaction">skin reactions</span>, and use of the drug should be discontinued at the first appearance of <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span> or any other sign of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-7.1.2"></a><p></p>
<h3><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span>/<span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span></h3>
<p class="First">There have been postmarketing reports of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> and <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span> associated with use of acetaminophen. Clinical signs included <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span> of the face, mouth, and throat, <span class="product-label-link" type="condition" conceptid="4158346" conceptname="Respiratory distress">respiratory distress</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>. There were frequent reports of life-threatening <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span> requiring emergency medical attention. Instruct patients to discontinue hydrocodone bitartrate and acetaminophen oral solution immediately and seek medical care if they experience these symptoms. Do not prescribe hydrocodone bitartrate and acetaminophen oral solution for patients with acetaminophen <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-7.2"></a><p></p>
<h2><span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">Respiratory Depression</span></h2>
<p class="First">At high doses or in sensitive patients, hydrocodone may produce dose-related <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span> by acting directly on the brain stem respiratory center. Hydrocodone also affects the center that controls respiratory rhythm, and may produce irregular and periodic breathing.</p>
<p>Infants may have increased sensitivity to the respiratory depressant effects of opioids (see<a href="#P_Peds"> PRECAUTIONS, Pediatric Use</a>). If use of hydrocodone bitartrate and acetaminophen in such patients is contemplated, it should be administered cautiously, in substantially reduced initial doses, by personnel experienced in administering opioids to infants, and with intensive monitoring.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-7.3"></a><p></p>
<h2><span class="product-label-link" type="condition" conceptid="375415" conceptname="Injury of head">Head Injury</span> and <span class="product-label-link" type="condition" conceptid="4154803" conceptname="Raised intracranial pressure">Increased Intracranial Pressure</span></h2>
<p class="First">The respiratory depressant effects of narcotics and their capacity to elevate cerebrospinal fluid pressure may be markedly exaggerated in the presence of <span class="product-label-link" type="condition" conceptid="375415" conceptname="Injury of head">head injury</span>, other intracranial lesions or a preexisting increase in intracranial pressure. Furthermore, narcotics produce adverse reactions, which may obscure the clinical course of patients with head injuries.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-7.4"></a><p></p>
<h2>Acute Abdominal Conditions</h2>
<p class="First">The administration of narcotics may obscure the diagnosis or clinical course of patients with acute abdominal conditions.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-7.5"></a><p></p>
<h2>Misuse, Abuse, and Diversion of Opioids</h2>
<p class="First">Hydrocodone bitartrate and acetaminophen oral solution contains hydrocodone, an opioid agonist, and is a Schedule II controlled substance. Opioid agonists have the potential for being abused and are sought by abusers and people with addiction disorders, and are subject to diversion.</p>
<p>Hydrocodone bitartrate and acetaminophen oral solution can be abused in a manner similar to other opioid agonists, legal or illicit. This should be considered when prescribing or dispensing hydrocodone bitartrate and acetaminophen oral solution in situations where the physician or pharmacist is concerned about an increased risk of misuse, abuse or diversion (see<a href="#DAD"> DRUG ABUSE AND <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">DEPENDENCE</span></a>).</p>
</div>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-8"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="section-8.1"></a><p></p>
<h2>General</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="section-8.1.1"></a><p></p>
<h3>Special Risk Patients</h3>
<p class="First">As with any narcotic analgesic agent, hydrocodone bitartrate and acetaminophen oral solution should be used with caution in elderly or debilitated patients, and those with severe impairment of hepatic or renal function, <span class="product-label-link" type="condition" conceptid="140673" conceptname="Hypothyroidism">hypothyroidism</span>, Addison's disease, <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span> or <span class="product-label-link" type="condition" conceptid="195590" conceptname="Urethral stricture">urethral stricture</span>. The usual precautions should be observed and the possibility of <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span> should be kept in mind.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-8.1.2"></a><p></p>
<h3><span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">Cough</span> Reflex</h3>
<p class="First">Hydrocodone suppresses the <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough</span> reflex; as with all narcotics, caution should be exercised when hydrocodone bitartrate and acetaminophen oral solution are used postoperatively and in patients with pulmonary disease.</p>
</div>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="info"></a><a name="section-8.2"></a><p></p>
<h2>Information for Patients/Caregivers</h2>
<ul class="Disc">
<li><span class="Bold">Do not take hydrocodone bitartrate and acetaminophen oral solution if you are allergic to any of its ingredients.</span></li>
<li><span class="Bold">If you develop signs of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span> such as <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span> or <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">difficulty breathing</span>, stop taking hydrocodone bitartrate and acetaminophen oral solution and contact your healthcare provider immediately.</span></li>
<li><span class="Bold">Do not take more than 4000 milligrams of acetaminophen per day. Call your doctor if you took more than the recommended dose.</span></li>
</ul>
<p class="First">Hydrocodone, like all narcotics, may impair mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. Such tasks should be avoided while taking this product.</p>
<p>Alcohol and other CNS depressants may produce an additive <span class="product-label-link" type="condition" conceptid="4171908" conceptname="Semicoma">CNS depression</span>, when taken with this combination product, and should be avoided.</p>
<p>Hydrocodone may be habit-forming. Patients should take the drug only for as long as it is prescribed, in the amounts prescribed, and no more frequently than prescribed.</p>
<p>Physicians should instruct patients and caregivers to read the patient information leaflet, which appears as the last section of the labeling.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="section-8.3"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">In patients with severe hepatic or <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>, effects of therapy should be monitored with serial liver and/or renal function tests.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-8.4"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Patients receiving narcotics, antihistamines, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone bitartrate and acetaminophen oral solution may exhibit an additive <span class="product-label-link" type="condition" conceptid="4171908" conceptname="Semicoma">CNS depression</span>. When combined therapy is contemplated, the dose of one or both agents should be reduced.</p>
<p>The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.</p>
</div>
<div class="Section" data-sectionCode="34074-5">
<a name="section-8.5"></a><p></p>
<h2>Drug/Laboratory Test Interactions</h2>
<p class="First">Acetaminophen may produce false-positive test results for urinary 5-hydroxyindoleacetic acid.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-8.6"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">No adequate studies have been conducted in animals to determine whether hydrocodone has a potential for carcinogenesis, mutagenesis, or impairment of fertility.</p>
<p>Hydrocodone has not demonstrated mutagenic potential using the Ames <span class="product-label-link" type="condition" conceptid="4235289" conceptname="Salmonellosis">Salmonella</span>-Microsomal Activation test, the Basc test on Drosophila germ cells, and the Micronucleus test on mouse bone marrow.</p>
<p>No adequate studies have been conducted in animals to determine whether acetaminophen has a potential for carcinogenesis, mutagenesis, or impairment of fertility.</p>
<p>Acetaminophen has not demonstrated mutagenic potential using the Ames <span class="product-label-link" type="condition" conceptid="4235289" conceptname="Salmonellosis">Salmonella</span>-Microsomal Activation test, the Basc test on Drosophila germ cells, and the Micronucleus test on mouse bone marrow.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-8.7"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="section-8.7.1"></a><p></p>
<h3>Teratogenic Effects</h3>
<div class="Section" data-sectionCode="42229-5">
<a name="section-8.7.1.1"></a><p></p>
<h4>Pregnancy Category C</h4>
<p class="First">There are no adequate and well-controlled studies in pregnant women. Hydrocodone bitartrate and acetaminophen oral solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.</p>
</div>
</div>
<div class="Section" data-sectionCode="34078-6">
<a name="section-8.7.2"></a><p></p>
<h3>Nonteratogenic Effects</h3>
<p class="First">Babies born to mothers who have been taking opioids regularly prior to delivery will be physically dependent. The withdrawal signs include <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span> and excessive <span class="product-label-link" type="condition" conceptid="4136768" conceptname="Crying">crying</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremors</span>, <span class="product-label-link" type="condition" conceptid="4137162" conceptname="Overactive">hyperactive</span> reflexes, increased <span class="product-label-link" type="condition" conceptid="4313591" conceptname="Respiratory rate">respiratory rate</span>, increased stools, <span class="product-label-link" type="condition" conceptid="4328356" conceptname="Sneezing">sneezing</span>, <span class="product-label-link" type="condition" conceptid="4089239" conceptname="Yawning">yawning</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> and <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>. These signs usually appear during the first few days of life. The intensity of the syndrome does not always correlate with the duration of maternal opioid use or dose. There is no consensus on the best method of managing withdrawal.</p>
</div>
</div>
<div class="Section" data-sectionCode="34079-4">
<a name="section-8.8"></a><p></p>
<h2>Labor and Delivery</h2>
<p class="First">Narcotic analgesics cross the placental barrier. The closer to delivery and the larger the dose used, the greater the possibility of <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span> in the newborn. Narcotic analgesics should be avoided during labor if delivery of a premature infant is anticipated. If the mother has received narcotic analgesics during labor, newborn infants should be observed closely for signs of <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span>. Resuscitation may be required (see<a href="#OVERDOSAGE"> OVERDOSAGE</a>). The effect of hydrocodone, if any, on the later growth, development, and functional maturation of the child is unknown.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-8.9"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">Acetaminophen is excreted in breast milk in small amounts, but the significance of its effects on nursing infants is not known. It is not known whether hydrocodone is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from hydrocodone and acetaminophen, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="P_Peds"></a><a name="section-8.10"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness in the pediatric population below the age of two years have not been established. Use of hydrocodone bitartrate and acetaminophen oral solution in the pediatric population is supported by the evidence from adequate and well-controlled studies of hydrocodone and acetaminophen combination products in adults with additional data which support the development of metabolic pathways in children two years of age and over (see<a href="#DA"> DOSAGE AND ADMINISTRATION </a>for pediatric dosage information).</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="section-8.11"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">Clinical studies of hydrocodone bitartrate and acetaminophen oral solution did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.</p>
<p>Hydrocodone and the major metabolites of acetaminophen are known to be substantially excreted by the kidney. Thus the risk of toxic reactions may be greater in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span> due to the accumulation of the parent compound and/or metabolites in the plasma. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</p>
<p>Hydrocodone may cause <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span> and over-sedation in the elderly; elderly patients generally should be started on low doses of hydrocodone bitartrate and acetaminophen oral solution and observed closely.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-9"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First"><span class="Bold">To report SUSPECTED ADVERSE REACTIONS, contact VistaPharm, Inc. at 1-727-530-1633, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.</span></p>
<p>Potential effects of high dosage are also listed in the OVERDOSAGE section.</p>
<p><span class="Bold">Cardio-renal:</span>  <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">Bradycardia</span>, <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span>, <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">circulatory collapse</span>, renal toxicity, <span class="product-label-link" type="condition" conceptid="444044" conceptname="Acute tubular necrosis">renal tubular necrosis</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>.</p>
<p><span class="Bold">Central Nervous System/Psychiatric: </span><span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">Anxiety</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="4148767" conceptname="Dysphoric mood">dysphoria</span>, <span class="product-label-link" type="condition" conceptid="4142453" conceptname="Feeling high">euphoria</span>, <span class="product-label-link" type="condition" conceptid="4029621" conceptname="Fear">fear</span>, <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">general malaise</span>, impairment of mental and physical performance, <span class="product-label-link" type="condition" conceptid="4061577" conceptname="Lethargy">lethargy</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">lightheadedness</span>, mental clouding, <span class="product-label-link" type="condition" conceptid="4078201" conceptname="Mood swings">mood changes</span>, psychological <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">dependence</span>, sedation, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span> progressing to <span class="product-label-link" type="condition" conceptid="4229897" conceptname="Stupor">stupor</span> or <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>.</p>
<p><span class="Bold">Endocrine: </span><span class="product-label-link" type="condition" conceptid="380688" conceptname="Hypoglycemic coma">Hypoglycemic coma</span>.</p>
<p><span class="Bold">Gastrointestinal System: </span><span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">Abdominal pain</span>, <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>, gastric distress, <span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">heartburn</span>, <span class="product-label-link" type="condition" conceptid="4337543" conceptname="Hepatic necrosis">hepatic necrosis</span>, <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>, occult blood loss, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="4027663" conceptname="Peptic ulcer">peptic ulcer</span>, and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>.</p>
<p><span class="Bold">Genitourinary System: </span>Spasm of vesical sphincters, ureteral spasm, and <span class="product-label-link" type="condition" conceptid="192450" conceptname="Retention of urine">urinary retention</span>.</p>
<p><span class="Bold">Hematologic: </span><span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">Agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">hemolytic anemia</span>, <span class="product-label-link" type="condition" conceptid="433168" conceptname="Iron deficiency anemia secondary to inadequate dietary iron intake">iron deficiency anemia</span>, prolonged <span class="product-label-link" type="condition" conceptid="4219104" conceptname="Bleeding time">bleeding time</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>.</p>
<p><span class="Bold"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span>: </span><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergic reactions</span>.</p>
<p><span class="Bold">Musculoskeletal: </span>Skeletal muscle <span class="product-label-link" type="condition" conceptid="4002033" conceptname="Muscle relaxation">flaccidity</span>.</p>
<p><span class="Bold"><span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">Respiratory Depression</span>: </span>Acute airway obstruction, <span class="product-label-link" type="condition" conceptid="321689" conceptname="Apnea">apnea</span>, dose-related <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span> (see<a href="#OVERDOSAGE"> OVERDOSAGE</a>), <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">shortness of breath</span>.</p>
<p><span class="Bold">Special Senses: </span>Cases of hearing impairment or permanent loss have been reported predominantly in patients with <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">chronic overdose</span>.</p>
<p><span class="Bold">Skin: </span><span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">Cold</span> and <span class="product-label-link" type="condition" conceptid="4308436" conceptname="Cold sweat">clammy</span> skin, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">diaphoresis</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>.</p>
</div>
<div class="Section" data-sectionCode="42227-9">
<a name="DAD"></a><a name="section-10"></a><p></p>
<h1>DRUG ABUSE AND <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">DEPENDENCE</span></h1>
<div class="Section" data-sectionCode="34086-9">
<a name="section-10.1"></a><p></p>
<h2>Misuse, Abuse, and Diversion of Opioids</h2>
<p class="First">Hydrocodone bitartrate and acetaminophen oral solution contains hydrocodone, an opioid agonist, and is a Schedule II controlled substance. Hydrocodone bitartrate and acetaminophen oral solution and other opioids used in <span class="product-label-link" type="condition" conceptid="4242687" conceptname="No sensitivity to pain">analgesia</span> can be abused and are subject to criminal diversion.</p>
<p>Addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. It is characterized by behaviors that include one or more of the following: impaired control over drug use, compulsive use, continued use despite harm, and craving. <span class="product-label-link" type="condition" conceptid="440069" conceptname="Drug dependence">Drug addiction</span> is a treatable disease utilizing a multidisciplinary approach, but relapse is common.</p>
<p>"Drug seeking" behavior is very common in addicts and drug abusers. Drug-seeking tactics include emergency calls or visits near the end of office hours, refusal to undergo appropriate examination, testing or referral, repeated "loss" of prescriptions, tampering with prescriptions and reluctance to provide prior medical records or contact information for other treating physician(s). "Doctor shopping" to obtain additional prescriptions is common among drug abusers and people suffering from untreated addiction.</p>
<p>Abuse and addiction are separate and distinct from physical <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">dependence</span> and tolerance. Physical <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">dependence</span> usually assumes clinically significant dimensions only after several weeks of continued opioid use, although a mild degree of physical <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">dependence</span> may develop after a few days of opioid therapy. Tolerance, in which increasingly large doses are required in order to produce the same degree of <span class="product-label-link" type="condition" conceptid="4242687" conceptname="No sensitivity to pain">analgesia</span>, is manifested initially by a shortened duration of <span class="product-label-link" type="condition" conceptid="4242687" conceptname="No sensitivity to pain">analgesic effect</span>, and subsequently by decreases in the intensity of <span class="product-label-link" type="condition" conceptid="4242687" conceptname="No sensitivity to pain">analgesia</span>. The rate of development of tolerance varies among patients. Physicians should be aware that abuse of opioids can occur in the absence of true addiction and is characterized by misuse for nonmedical purposes, often in combination with other psychoactive substances. Recordkeeping of prescribing information, including quantity, frequency, and renewal requests is strongly advised.</p>
<p>Proper assessment of the patient, proper prescribing practices, periodic reevaluation of therapy, and proper dispensing and storage are appropriate measures that help to limit abuse of opioid drugs.</p>
</div>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="OVERDOSAGE"></a><a name="section-11"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">Following an acute overdosage, toxicity may result from hydrocodone or acetaminophen.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="section-11.1"></a><p></p>
<h2>Signs and Symptoms</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="section-11.1.1"></a><p></p>
<h3>Hydrocodone</h3>
<p class="First">Serious <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> with hydrocodone is characterized by <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span> (a decrease in <span class="product-label-link" type="condition" conceptid="4313591" conceptname="Respiratory rate">respiratory rate</span> and/or tidal volume, Cheyne-Stokes respiration, <span class="product-label-link" type="condition" conceptid="438555" conceptname="Cyanosis">cyanosis</span>), extreme <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span> progressing to <span class="product-label-link" type="condition" conceptid="4229897" conceptname="Stupor">stupor</span> or <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>, skeletal muscle <span class="product-label-link" type="condition" conceptid="4002033" conceptname="Muscle relaxation">flaccidity</span>, <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">cold</span>, and <span class="product-label-link" type="condition" conceptid="4308436" conceptname="Cold sweat">clammy</span> skin, and sometimes <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span> and <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>. In severe overdosage, <span class="product-label-link" type="condition" conceptid="321689" conceptname="Apnea">apnea</span>, <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">circulatory collapse</span>, <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span> and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> may occur.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-11.1.2"></a><p></p>
<h3>Acetaminophen</h3>
<p class="First">In acetaminophen overdosage: dose-dependant, potentially fatal <span class="product-label-link" type="condition" conceptid="4337543" conceptname="Hepatic necrosis">hepatic necrosis</span> is the most serious adverse effect. <span class="product-label-link" type="condition" conceptid="444044" conceptname="Acute tubular necrosis">Renal tubular necrosis</span>, <span class="product-label-link" type="condition" conceptid="380688" conceptname="Hypoglycemic coma">hypoglycemic coma</span> and coagulation defects may also occur. Early symptoms following a potentially hepatoxic <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> may include: <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">diaphoresis</span> and <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">general malaise</span>. Clinical and laboratory evidence of hepatic toxicity may not be apparent until 48 to 72 hours post-ingestion.</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-11.2"></a><p></p>
<h2>Treatment</h2>
<p class="First">A single or <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">multiple drug overdose</span> with hydrocodone and acetaminophen is a potentially lethal polydrug <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, and consultation with a regional poison control center is recommended. Immediate treatment includes support of cardiorespiratory function and measures to reduce drug absorption. Oxygen, intravenous fluids, vasopressors, and other supportive measures should also be considered.</p>
<p>For hydrocodone <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, primary attention should be given to the reestablishment of adequate respiratory exchange through provision of a patent airway and the institution of assisted or controlled ventilation. The narcotic antagonist naloxone hydrochloride is a specific antidote against respiratory depressure which may result from overdosage or unusual sensitivity to narcotics, including hydrocodone. Since the duration of action of hydrocodone may exceed that of the antagonist, the patient should be kept under continued surveillance, and repeated doses of the antagonist should be administered as needed to maintain adequate respiration. A narcotic antagonist should not be administered in the absence of clinically significant respiratory or cardiovascular <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>.</p>
<p>Gastric decontamination with activated charcoal should be administered just prior to N-acetylcysteine (NAC) to decrease systemic absorption if acetaminophen ingestion is known or suspected to have occurred within a few hours of presentation. Serum acetaminophen levels should be obtained immediately if the patient presents 4 hours or more after ingestion to assess potential risk of hepatotoxicity; acetaminophen levels drawn less than 4 hours post-ingestion may be misleading. To obtain the best possible outcome, NAC should be administered as soon as possible where impending or evolving <span class="product-label-link" type="condition" conceptid="4352876" conceptname="Liver damage">liver injury</span> is suspected. Intravenous NAC may be administered when circumstances preclude oral administration.</p>
<p>Vigorous supportive therapy is required in severe <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span>. Procedures to limit the continuing absorption of the drug must be readily performed since the hepatic injury is dose dependent and occurs early in the course of <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="DA"></a><a name="section-12"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Dosage should be adjusted according to severity of the <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> and the response of the patient. However, it should be kept in mind that tolerance to hydrocodone can develop with continued use and that the incidence of untoward effects is dose related.</p>
<p>The usual adult dosage is one tablespoonful every 4 to 6 hours as needed for <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>. The total daily dosage for adults should not exceed 6 tablespoonfuls.</p>
<p>The usual dosages for children are given by the table below, and are to be given every 4 to 6 hours as needed for <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>. These dosages correspond to an average individual dose of 0.27 mL/kg of hydrocodone bitartrate and acetaminophen oral solution (providing 0.135 mg/kg of hydrocodone bitartrate and 5.85 mg/kg of acetaminophen). Dosing should be based on weight whenever possible.</p>
<table width="75%">
<col align="left" valign="top" width="25%">
<col align="center" valign="middle" width="25%">
<col align="center" valign="top" width="25%">
<col align="center" valign="top" width="25%">
<thead><tr class="First Last">
<th class="Lrule Rrule" align="center">Body<br>Weight</th>
<th class="Rrule" align="center">Approximate<br>Age</th>
<th class="Rrule" align="center">Dose<br>every 4 to 6 hours</th>
<th class="Rrule" align="center">MAXIMUM TOTAL<br>DAILY DOSE<br>(6 doses per day)</th>
</tr></thead>
<tbody>
<tr class="Botrule First">
<td class="Lrule Rrule" align="left">12 to 15 kg<br>27 to 34 lbs.</td>
<td class="Rrule" align="center">2 to 3 years</td>
<td class="Rrule" align="center">¾ teaspoonful<br>= 3.75 mL</td>
<td class="Rrule" align="center">4½ teaspoonfuls<br>= 22.5 mL</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">16 to 22 kg<br>35 to 50 lbs</td>
<td class="Rrule" align="center">4 to 6 years</td>
<td class="Rrule" align="center">1 teaspoonful<br>= 5 mL</td>
<td class="Rrule" align="center">6 teaspoonfuls<br>= 30 mL</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">23 to 31 kg<br>51 to 69 lbs</td>
<td class="Rrule" align="center">7 to 9 years</td>
<td class="Rrule" align="center">1½ teaspoonfuls<br>= 7.5 mL</td>
<td class="Rrule" align="center">9 teaspoonfuls<br>= 45 mL</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">32 to 45 kg<br>70 to 100 lbs.</td>
<td class="Rrule" align="center">10 to 13 years</td>
<td class="Rrule" align="center">2 teaspoonfuls<br>= 10 mL</td>
<td class="Rrule" align="center">12 teaspoonfuls<br>= 60 mL</td>
</tr>
<tr class="Last">
<td class="Lrule Rrule" align="left">46 kg and up<br>101 lbs. and up</td>
<td class="Rrule" align="center">14 years to adult</td>
<td class="Rrule" align="center">1 Tablespoonful<br>= 15 mL</td>
<td class="Rrule" align="center">6 Tablespoonfuls<br>= 90 mL</td>
</tr>
</tbody>
</table>
<p>The total daily dosage for children should not exceed 6 doses per day.</p>
<p>It is of utmost importance that the dose of hydrocodone bitartrate and acetaminophen oral solution be administered accurately. A household teaspoon or tablespoon is not an adequate measuring device, especially when one-half or three-fourths of a teaspoonful is to be measured. Given the inexactitude of the household spoon measure and the possibility of using a tablespoon instead of a teaspoon, which could lead to overdosage, it is strongly recommended that caregivers obtain and use a calibrated measuring device. Health care providers should recommend a dropper that can measure and deliver the prescribed dose accurately, and instruct caregivers to use extreme caution in measuring the dosage.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-13"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Hydrocodone bitartrate and acetaminophen oral solution, 7.5 mg/325 mg per 15 mL is a red-colored, wild cherry flavored liquid containing hydrocodone bitartrate<span class="Bold"> (WARNING: may be habit-forming) </span>7.5 mg and acetaminophen 325 mg per 15 mL, with alcohol 8.6% v/v. It is supplied in the following containers:</p>
<p><span class="Bold">7.5 mg/325 mg per 15 mL</span></p>
<p>NDC 66689-023-50: Case contains 50 unit dose cups of 15 mL (NDC 66689-023-01), packaged in 5 trays of 10 unit dose cups each.</p>
<p>NDC 66689-023-04: Bottles of 4 fl. oz. (120 mL).</p>
<p>NDC 66689-023-16: Bottles of 16 fl. oz. (473 mL).</p>
<div class="Section" data-sectionCode="44425-7">
<a name="section-13.1"></a><p></p>
<h2>STORAGE</h2>
<p class="First">Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-14"></a><p></p>
<h1>PHARMACIST</h1>
<p class="First">Dispense in a tight, light-resistant container with a child-resistant closure.<span class="Bold"> DISPENSE WITH PATIENT INFORMATION LEAFLET.</span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-15"></a><p></p>
<p class="First"><span class="Bold">Hydrocodone Bitartrate and Acetaminophen Oral Solution</span></p>
<p>7.5 mg/325 mg per 15 mL</p>
<p>CII</p>
<p>A Schedule CII Narcotic.</p>
<p>Manufactured by:<br><span class="Bold Italics">VistaPharm</span><br>Largo, FL 33771</p>
<p>VP2017R2<br>08/14</p>
<p>To request medical information or <span class="Bold">to report SUSPECTED ADVERSE REACTIONS, contact VistaPharm, Inc. at 1-727-530-1633 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.</span></p>
</div>
<div class="Section" data-sectionCode="42230-3">
<a name="section-16"></a><p></p>
<h1>Patient Information Leaflet</h1>
<p class="First"><span class="Bold">Hydrocodone Bitartrate and Acetaminophen Oral Solution</span><br>7.5 mg/325 mg per 15 mL (Cherry Flavored)<br>CII</p>
<p><span class="Bold">Summary</span></p>
<div class="Warning">
<a name="section-16.1"></a><p></p>
<p class="First"><span class="Bold">Hydrocodone bitartrate and acetaminophen oral solution is used to relieve moderate to moderately severe <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>. You should not take hydrocodone bitartrate and acetaminophen oral solution if you are allergic to hydrocodone or acetaminophen. The most common side effects of hydrocodone bitartrate and acetaminophen oral solution are <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">lightheadedness</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">shortness of breath</span>, unusual <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">tiredness</span>, and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>. Take this medicine as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.</span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-16.1"></a><p></p>
<p class="First"><span class="Bold">Uses</span></p>
<p>Hydrocodone bitartrate and acetaminophen oral solution is an analgesic used to relieve moderate to moderately severe <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>. Hydrocodone bitartrate and acetaminophen oral solution is a combination product containing hydrocodone (hye-droe-KO-done) bitartrate and acetaminophen (a-seat-a-MIN-oh-fen). Hydrocodone is a narcotic <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> reliever and a <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough</span> suppressant. Acetaminophen is a non-narcotic <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> reliever and <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> reducer. A narcotic analgesic and acetaminophen used together may provide better <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> relief than either product used alone. If you have any questions, please call your doctor or pharmacist.</p>
<p><span class="Bold">General Cautions</span></p>
<ul class="Disc">
<li>Do not take this drug if you have allergies or unusual reactions to narcotic <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> relievers or acetaminophen because it is likely that you may also be allergic to hydrocodone bitartrate and acetaminophen oral solution.</li>
<li>This product may inhibit your mental and physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. Such tasks should be avoided while you are taking this product.</li>
<li>This medicine may not be right for you. Check with your doctor or pharmacist, if you:<ul class="Circle">
<li>are pregnant.</li>
<li>are nursing.</li>
<li>are taking other medications: narcotic <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> relievers; <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span> medicines; antidepressant medicines; acetaminophen-containing medicines or other medicines that cause central nervous system <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, including alcohol.</li>
<li>have other medical problems: a history of drug or <span class="product-label-link" type="condition" conceptid="433753" conceptname="Alcohol abuse">alcohol abuse</span>; recent <span class="product-label-link" type="condition" conceptid="375415" conceptname="Injury of head">head injury</span>; <span class="product-label-link" type="condition" conceptid="4169883" conceptname="Emphysema">emphysema</span>, <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, or other chronic <span class="product-label-link" type="condition" conceptid="257907" conceptname="Disorder of lung">lung disease</span>; liver disease, kidney disease; underactive thyroid, Addison's disease, <span class="product-label-link" type="condition" conceptid="4093346" conceptname="Large prostate">enlarged prostate</span> or difficulty urinating.</li>
</ul>
</li>
</ul>
<p><span class="Bold">Proper Use</span></p>
<p>Take this medicine as directed by your doctor. Do not share it with anyone else. This medicine can cause <span class="product-label-link" type="condition" conceptid="440069" conceptname="Drug dependence">drug dependence</span> and has the potential for abuse. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. If you think that this medicine is not working properly after taking it for some time, do not increase the dose. Check with your doctor or pharmacist.</p>
<p><span class="Bold">Dosing</span></p>
<p>The dose of this medication will be different for different patients. Follow the directions provided by your doctor. The following information includes only the average doses of this medication.<span class="Italics"> If your dose is different, do not change doses unless your doctor tells you to do so.</span></p>
<table width="75%">
<col align="center" valign="top" width="25%">
<col align="center" valign="middle" width="25%">
<col align="center" valign="top" width="25%">
<col align="center" valign="top" width="25%">
<thead><tr class="First Last">
<th class="Lrule Rrule" align="center">Body Weight</th>
<th class="Rrule" align="center" valign="top">Approximate<br>Age</th>
<th class="Rrule" align="center">Dose Every<br>4 to 6 hours</th>
<th class="Rrule" align="center">MAXIMUM TOTAL<br>DAILY DOSE<br>(6 doses per day)<br>7.5 mg/325 mg per<br>15 mL</th>
</tr></thead>
<tbody>
<tr class="Botrule First">
<td class="Lrule Rrule" align="center">12 to 15 kg<br>27 to 34 lbs.</td>
<td class="Rrule" align="center">2 to 3 years</td>
<td class="Rrule" align="center">¾ teaspoonful<br>= 3.75 mL</td>
<td class="Rrule" align="center">4½ teaspoonfuls<br>= 22.5 mL</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="center">16-22 kg<br>35-50 lbs</td>
<td class="Rrule" align="center">4-6 years</td>
<td class="Rrule" align="center">1 teaspoonful<br>= 5 mL</td>
<td class="Rrule" align="center">6 teaspoonfuls<br>= 30 mL</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="center">23-31 kg<br>51-69 lbs</td>
<td class="Rrule" align="center">7-9 years</td>
<td class="Rrule" align="center">1½ teaspoonfuls<br>= 7.5 mL</td>
<td class="Rrule" align="center">9 teaspoonfuls<br>= 45 mL</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="center">32-45 kg<br>70-100 lbs.</td>
<td class="Rrule" align="center">10-13 years</td>
<td class="Rrule" align="center">2 teaspoonfuls<br>= 10 mL</td>
<td class="Rrule" align="center">12 teaspoonfuls<br>= 60 mL</td>
</tr>
<tr class="Last">
<td class="Lrule Rrule" align="center">46 kg and up<br>101 lbs. and up</td>
<td class="Rrule" align="center">14 years to adult</td>
<td class="Rrule" align="center">1 Tablespoonful<br>= 15 mL</td>
<td class="Rrule" align="center">6 Tablespoonfuls<br>= 90 mL</td>
</tr>
</tbody>
</table>
<p>It is very important that hydrocodone bitartrate and acetaminophen oral solution be dosed accurately. A household teaspoon or tablespoon is not an accurate measuring device, especially when one-half or three-fourths of a teaspoonful is to be measured.</p>
<p>Since a household teaspoon is not accurate and can be mixed-up with a tablespoon (which can cause overdosage), it is strongly recommended that you obtain and use a proper measuring device. Ask your doctor or pharmacist for help to find a dropper that can measure the needed dose properly and ask for help if you do not understand how to use the dropper.</p>
<p><span class="Bold">Missed Dose</span></p>
<ul class="Disc">
<li>To avoid a possible <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, it is important that you do not take more than a single dosage at one time, or that you don't take doses at intervals less than 4 hours apart.</li>
<li>If you miss taking a dose of hydrocodone bitartrate and acetaminophen oral solution, take it as soon as you remember. However, make sure to wait at least 4 hours before taking your next dose.</li>
<li>If you missed taking a dose, and it is almost time for your next dose, skip the missed dose and take your medicine as scheduled.</li>
<li>Do not double the prescribed dose.</li>
</ul>
<p><span class="Bold">Possible Side Effects</span></p>
<p>Side effects you may experience include <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>, <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>, difficulty urinating, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="4029621" conceptname="Fear">fear</span>, fuzzy thinking, general feeling of <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> or illness, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">lightheadedness</span>, <span class="product-label-link" type="condition" conceptid="4078201" conceptname="Mood swings">mood changes</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">shortness of breath</span>, slower reactions, unusual <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">tiredness</span>, and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>.</p>
<p>Call your doctor if these effects continue or are bothersome.</p>
<p>Side effects not listed above may sometimes occur. If you notice any other effects, check with your doctor.<span class="Bold"> To report side effects contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch</span></p>
<p><span class="Bold">Storage</span></p>
<ul class="Disc">
<li>Keep out of reach of children.</li>
<li>Store at room temperature (protect from heat, do not refrigerate).</li>
<li>Keep in original labeled bottle.</li>
<li>Discard medicines that are old or no longer needed.</li>
<li>Even a single <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> of this medicine may be a life-threatening situation. If you suspect that you or someone else may have taken more than the prescribed dose of this medicine, contact your local poison control center or emergency room immediately. This medicine was prescribed for your particular condition. Do not use it for another condition or give the drug to others.</li>
<li>This leaflet provides a summary of information about hydrocodone bitartrate and acetaminophen oral solution. If you have any questions or concerns, or want more information about hydrocodone bitartrate and acetaminophen oral solution, contact your doctor or pharmacist. Your pharmacist also has a longer leaflet about hydrocodone bitartrate and acetaminophen oral solution that is written for health professionals that you can ask to read.</li>
</ul>
<p><span class="Bold">Manufactured by:<br><span class="Italics">VistaPharm</span><br>Largo, FL 33771</span></p>
<p>VP2017R2<br>08/14</p>
<p>To request medical information or <span class="Bold">to report SUSPECTED ADVERSE REACTIONS, contact VistaPharm, Inc. at 1-727-530-1633 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.</span></p>
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-17"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label</h1>
<p class="First">NDC 66689-023-16</p>
<p><span class="Bold Italics">VistaPharm</span><br><span class="Bold">CII</span></p>
<p><span class="Bold">HYDROCODONE BITARTRATE AND<br>ACETAMINOPHEN ORAL SOLUTION</span></p>
<p><span class="Bold">7.5 mg/325 mg per 15 mL</span><br>(Cherry Flavored)<br><span class="Bold">DISPENSE WITH PATIENT INFORMATION LEAFLET.</span></p>
<p>Contains:    Per 5 mL    Per 15 mL</p>
<p>Hydrocodone Bitartrate    2.5 mg    7.5 mg<br><span class="Bold">WARNING: May be habit-forming</span><br>Acetaminophen    108 mg    325 mg<br>Alcohol    8.6% v/v    8.6% v/v</p>
<p><span class="Bold">473 mL</span></p>
<p><span class="Bold">Rx<br>only</span></p>
<p><span class="Bold">VP2021R1</span></p>
<div class="Figure"><img alt="Principal Display Panel - 473 mL Bottle Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=41ebe34d-567d-4fea-9fcb-c93e990a7861&amp;name=hydrocodone-03.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>HYDROCODONE BITARTRATE AND ACETAMINOPHEN 		
					</strong><br><span class="contentTableReg">hydrocodone bitartrate and acetaminophen solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:66689-023</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">CII    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Hydrocodone Bitartrate</strong> (Hydrocodone) </td>
<td class="formItem">Hydrocodone Bitartrate</td>
<td class="formItem">7.5 mg  in 15 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>Acetaminophen</strong> (Acetaminophen) </td>
<td class="formItem">Acetaminophen</td>
<td class="formItem">325 mg  in 15 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Anhydrous Citric Acid</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Ethyl Maltol</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Glycerin</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Methylparaben</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Propylene Glycol</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Propylparaben</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Water</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Saccharin Sodium</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Trisodium Citrate Dihydrate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Sorbitol</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Sucrose</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C Red No. 40</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">RED</td>
<td class="formLabel">Score</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem">CHERRY</td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:66689-023-50</td>
<td class="formItem">50  in 1 CASE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:66689-023-01</td>
<td class="formItem">15 mL in 1 CUP, UNIT-DOSE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:66689-023-16</td>
<td class="formItem">473 mL in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:66689-023-04</td>
<td class="formItem">120 mL in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA200343</td>
<td class="formItem">02/20/2012</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>VistaPharm Inc.
							(116743084)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">VistaPharm Inc.</td>
<td class="formItem"></td>
<td class="formItem">116743084</td>
<td class="formItem">MANUFACTURE(66689-023)</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">VistaPharm Inc.</td>
<td class="formItem"></td>
<td class="formItem">125330188</td>
<td class="formItem">ANALYSIS(66689-023)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 9/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>d529e9a6-1036-42ba-9215-068e07cba97e</div>
<div>Set id: 41ebe34d-567d-4fea-9fcb-c93e990a7861</div>
<div>Version: 4</div>
<div>Effective Time: 20140925</div>
</div>
</div> <div class="DistributorName">VistaPharm Inc.</div></p>
</body></html>
